|
From Collegiate Presswire's RadioWire (https://www.cpwire.com/radio): Radio There�s good news today for the millions of adults who suffer from depression. The U.S. Food and Drug Administration has just approved Wellbutrin XL� (bupropion hydrochloride extended-release tablets) for the treatment of major depressive disorder. Experts say the new once-daily medication provides important benefits for patients including effective treatment for depression and a low risk of sexual side effects and weight gain. Doctor James Pradko, a practicing physician, and Director of the Bay Pointe Depression Clinic (Detroit, MI).
�With the FDA approval of Wellbutrin XL, we have an important new once-daily medication to treat depression in adults. Wellbutrin XL offers patients an effective, convenient, once-daily treatment for depression, with a low risk of sexual dysfunction and weight gain.�
Depression affects up to 14 million adults or 6.6 percent of the U.S. population in a given year and there is more than a 16 percent lifetime chance of developing depression. Women are more often affected, experiencing depression at nearly twice the rate of men.
Anncr: Wellbutrin XL is not for everyone. If you take Wellbutrin XL there is a risk you may have a seizure. Do not take if you have or had a seizure or eating disorder. Don�t use if you take an MAOI, or any medicine that contains bupropion such as Wellbutrin SR or Zyban. You should not take Wellbutrin XL if you are abruptly stopping the use of alcohol or sedatives. When used with a nicotine patch or alone, there is a risk of increased blood pressure, sometimes severe. The weight loss potential of Welbutrin XL should be considered if weight loss is a major presenting sign of the depressive illness. To reduce risk of serious side effects, tell your doctor if you have liver or kidney problems. Other side effects may include weight loss, dry mouth, nausea, difficulty sleeping, dizziness and sore throat.
CLICK HERE to download a transcript of this story: CLICK HERE to download a multimedia (MP3) file of this story: © Copyright 2003 Collegiate Presswire, Inc. and NBN/CP RadioWire |